Baseline characteristics

A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma · Source last updated 2021-06-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      3

   2. group Id

      BG001

      value

      5

   3. group Id

      BG002

      value

      8

   units

   Participants

groups

1. description

   Participants positive for t(11;14) translocation who received at least 1 dose of study drug (venetoclax 400 mg, pomalidomide 4 mg, and dexamethasone 40 mg)

   id

   BG000

   title

   Participants Positive for t(11;14) Translocation

2. description

   Participants negative for t(11;14) translocation who received at least 1 dose of study drug (venetoclax 400 mg, pomalidomide 4 mg, and dexamethasone 40 mg)

   id

   BG001

   title

   Participants Negative for t(11;14) Translocation

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            lower Limit

            67

            upper Limit

            74

            value

            68.0

         2. group Id

            BG001

            lower Limit

            60

            upper Limit

            77

            value

            66.0

         3. group Id

            BG002

            lower Limit

            60

            upper Limit

            77

            value

            67.5

   dispersion Type

   FULL_RANGE

   param Type

   MEDIAN

   title

   Age, Continuous

   unit Of Measure

   years

2. calculate Pct

   false

   classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            1

         2. group Id

            BG001

            value

            4

         3. group Id

            BG002

            value

            5

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            2

         2. group Id

            BG001

            value

            1

         3. group Id

            BG002

            value

            3

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. calculate Pct

   false

   classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            3

         2. group Id

            BG001

            value

            4

         3. group Id

            BG002

            value

            7

      title

      White

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            1

         3. group Id

            BG002

            value

            1

      title

      Black/African American

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

      title

      Asian

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

      title

      Other

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

population Description

Full Analysis Set: participants who received at least 1 dose of study drug

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice